FibroBiologics, Inc.
FBLG
$0.5998
-$0.0052-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.98% | 16.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.90% | 22.06% | |||
| Operating Income | 0.90% | -22.06% | |||
| Income Before Tax | 6.20% | -60.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.20% | -60.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.20% | -60.25% | |||
| EBIT | 0.90% | -22.06% | |||
| EBITDA | 1.07% | -22.18% | |||
| EPS Basic | 10.93% | -49.12% | |||
| Normalized Basic EPS | 10.87% | -48.94% | |||
| EPS Diluted | 10.93% | -49.12% | |||
| Normalized Diluted EPS | 10.87% | -48.94% | |||
| Average Basic Shares Outstanding | 5.35% | 7.46% | |||
| Average Diluted Shares Outstanding | 5.35% | 7.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||